These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 9858426)

  • 21. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.
    Choi HK; Seeger JD; Kuntz KM
    Arthritis Rheum; 2000 Oct; 43(10):2316-27. PubMed ID: 11037892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
    van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Kerstens PJ; Dijkmans BA; Boers M
    Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.
    Li SC; Feldman BM; Higgins GC; Haines KA; Punaro MG; O'Neil KM
    J Rheumatol; 2010 Jan; 37(1):175-81. PubMed ID: 19918041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey on the use of methotrexate by pediatric rheumatologists in Canada.
    Chédeville G; Scuccimarri R; Duffy CM
    J Rheumatol; 2007 Apr; 34(4):818-22. PubMed ID: 17309120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How do French rheumatologists treat early rheumatoid arthritis?
    de Asit N; Le Loët X; Czernichow P; Bertho JM; Delcambre B; Tonnel F; Loyau G; Dapogny C; Trèves R; Valat JP; Tauveron P; Sebert JL; Boumier P
    Rev Rhum Engl Ed; 1996 Mar; 63(3):188-95. PubMed ID: 8731236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
    Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
    J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada.
    Beukelman T; Guevara JP; Albert DA; Sherry DD; Burnham JM
    J Rheumatol; 2007 Sep; 34(9):1918-24. PubMed ID: 17787051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?
    Edworthy S; Zummer M; Garner S; Boire G; Leclercq S; Bykerk V; Kraag G; Markland J; Thomas D; Thomson J; Henderson J
    J Rheumatol; 2008 Aug; 35(8):1506-12. PubMed ID: 18597407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.
    Choi HK; Seeger JD; Kuntz KM
    J Rheumatol; 2002 Jun; 29(6):1156-65. PubMed ID: 12064828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current treatment by United States and Canadian pediatric rheumatologists.
    Cron RQ; Sharma S; Sherry DD
    J Rheumatol; 1999 Sep; 26(9):2036-8. PubMed ID: 10493688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating rheumatoid arthritis to target: a Canadian patient survey.
    Haraoui B; Bensen W; Thorne C; Wade J; Deamude M; Prince J; Légaré J
    J Clin Rheumatol; 2014 Mar; 20(2):61-7. PubMed ID: 24561407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
    Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
    J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.